Skip to main content

WELLINGTON MANAGEMENT GROUP LLP

Position in DNTH — Dianthus Therapeutics, Inc. /DE/

CIK 902219 Boston, MA

Position in DNTH

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$217,838,104
+$114,681,645 QoQ
Shares Held
2,595,783
+3.7% QoQ
Ownership
4.75%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 90.84900394216312.ToString("F0")% None 9.150996057836885.ToString("F0")%

Common Shares in DNTH Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

WELLINGTON MANAGEMENT GROUP LLP holds $14,418,547,095 across 180 Biotechnology names. DNTH ranks #24 (1.5% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in DNTH

Export CSV
7 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $217,838,104 2,595,783
2025-12-31 $103,156,459 2,503,190
2025-09-30 $101,430,998 2,577,662
2025-06-30 $1,385,158 74,351
2025-03-31 $1,233,192 67,982
2024-12-31 $1,315,346 60,337
2024-09-30 $1,472,632 53,785